| Financial Year |
March 31 2023 |
| Monetary Funds |
279,231,966.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
21,286,944.00 |
| Accounts Receivable |
777,098,647.91 |
| Advances to Suppliers |
8,630,181.49 |
| Other Receivables |
57,766,078.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
222,677,941.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,903,690.45 |
| Total Current Assets |
1,421,877,674.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,883,947.69 |
| Investment Properties |
9,541,947.97 |
| Fixed Assetes |
343,120,625.74 |
| Under-construction Projects |
369,096,730.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
282,050,583.08 |
| R&D expenses |
234,256,485.52 |
| Goodwill |
241,481,951.34 |
| Long-Term Deferred and Prepaid Expenses |
882,730.68 |
| Deferred Income Tax Assets |
135,900,644.40 |
| Other Non-Current Assets |
41,003,879.64 |
| Sub-Total of Non-Current Assets |
1,697,786,487.94 |
| Total Assets |
3,119,664,162.46 |
| Short-Term Loans |
103,165,364.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
277,765,564.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,001,622.42 |
| Taxes Payable |
8,890,621.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,566,726.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
28,385,236.29 |
| Other Current Liabilities |
489,801.91 |
| Sub-Total of Current Liabilities |
518,143,161.13 |
| Long-term Loans |
26,908,960.80 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,749.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
82,320,346.36 |
| Total Liabilities |
600,463,507.49 |
| Paid-In Capital(Or Share Stock) |
696,874,323.00 |
| Capital Surplus |
1,979,404,293.05 |
| Surplus Reserve |
58,735,173.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-214,890,580.84 |
| Minority Stockholder's Interest |
-41,098.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,519,241,753.07 |
| Owner's Equity（Stockholder's Equity） |
2,519,200,654.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,119,664,162.46 |
